IGF-1 LR3 Nasal Spray

Introduction

IGF-1 LR3 Nasal Spray is a research product featuring Insulin-Like Growth Factor 1 Long R3 (IGF-1 LR3), an extended variant of IGF-1 renowned for its heightened bioactivity. These vials are specifically crafted for precise and consistent use in research applications, adhering to rigorous quality control measures to ensure reliability

Key Characteristics

IGF-1 LR3 Nasal Spray is distinguished by the inclusion of the extended variant of Insulin-Like Growth Factor 1 (IGF-1 LR3), renowned for its advanced bioactivity, ensuring heightened efficacy in research applications. Meticulously formulated for precision, these vials provide researchers with a reliable source of IGF-1 LR3, facilitating accurate and reproducible results across experiments. Manufactured under stringent quality control measures, the product upholds reliability and integrity, meeting the high standards necessary for scientific research and experimentation.

Receptor Grade Vs Media Grade

Receptor Grade

• High Purity: Receptor Grade IGF-1 LR3 has a higher level of purity.
• Designed for Research: This grade is often used in scientific and research settings where high purity is crucial for accurate and consistent results.

Media Grade

• Lower Purity: Media Grade IGF-1 LR3 may have a lower purity compared to Receptor Grade.
• Commonly Used in Cell Culture Media: Media-grade peptides are sometimes used in cell culture media for various purposes.

Research Applications

IGF-1 LR3 Nasal Spray finds application in diverse scientific inquiries, specifically in studies focused on cellular growth, metabolism, and muscle-related conditions.

Research Benefits

May Potentially Promote Cell Division

Preliminary research indicates that IGF-1 LR3 may have the capacity to promote cell division, making it a compelling subject for investigations into cellular growth and regeneration.

Potentially Boosts Fat Metabolism And Fights Diabetes

Emerging studies suggest that IGF-1 LR3 may play a role in enhancing fat metabolism, presenting a potential avenue for research in diabetes management. This warrants further scrutiny in controlled research settings.

May Potentially Impair Myostatin

Early evidence suggests that IGF-1 LR3 may have the potential to impair myostatin, a key regulator of muscle growth. This provides opportunities for investigating conditions related to muscle development and wasting.